Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Journal of Geriatric Psychiatry and Neurology
|
October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease
N R Cutler, J J Sramek, M F Murphy, et al.
Life Sciences
|
August 18, 1986
Inhibition of mammalian digestive disaccharidases by polyhydroxy alkaloids
A M Scofield, L E Fellows, R J Nash, et al.
British Journal of Clinical Pharmacology
|
January 1, 1979
Psychomotor changes during initial day of benzodiazepine medication
J R Wittenborn, C F Flaherty, W E McGough, et al.
The Annals of Pharmacotherapy
|
September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease
N R Cutler, J J Sramek, M F Murphy, et al.
Fitoterapia
|
July 14, 2001
Constituents of Cassia laevigata
L Jones, B Bartholomew, Z Latif, et al.
Psychopharmacology Bulletin
|
April 1, 1979
Psychomotor changes during the initial day of benzodiazepine medication [proceedings]
J R Wittenborn, C F Flaherty, W E McGough, et al.
Theoretical Population Biology
|
February 1, 1997
Stability of a perturbed Leslie model
J P Quinn, R J Nash, A Georgallas, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 15, 2007
Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity
A Kato, H Yasuko, H Goto, et al.
Glycobiology
|
March 1, 1997
Homonojirimycin and N-methyl-homonojirimycin inhibit N-linked oligosaccharide processing
Y Zeng, Y T Pan, N Asano, et al.
Carbohydrate Research
|
October 31, 1996
Calystegine B4, a novel trehalase inhibitor from Scopolia japonica
N Asano, A Kato, H Kizu, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Journal of Geriatric Psychiatry and Neurology
|
October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease
N R Cutler, J J Sramek, M F Murphy, et al.
Life Sciences
|
August 18, 1986
Inhibition of mammalian digestive disaccharidases by polyhydroxy alkaloids
A M Scofield, L E Fellows, R J Nash, et al.
British Journal of Clinical Pharmacology
|
January 1, 1979
Psychomotor changes during initial day of benzodiazepine medication
J R Wittenborn, C F Flaherty, W E McGough, et al.
The Annals of Pharmacotherapy
|
September 1, 1992
Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease
N R Cutler, J J Sramek, M F Murphy, et al.
Fitoterapia
|
July 14, 2001
Constituents of Cassia laevigata
L Jones, B Bartholomew, Z Latif, et al.
Psychopharmacology Bulletin
|
April 1, 1979
Psychomotor changes during the initial day of benzodiazepine medication [proceedings]
J R Wittenborn, C F Flaherty, W E McGough, et al.
Theoretical Population Biology
|
February 1, 1997
Stability of a perturbed Leslie model
J P Quinn, R J Nash, A Georgallas, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 15, 2007
Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity
A Kato, H Yasuko, H Goto, et al.
Glycobiology
|
March 1, 1997
Homonojirimycin and N-methyl-homonojirimycin inhibit N-linked oligosaccharide processing
Y Zeng, Y T Pan, N Asano, et al.
Carbohydrate Research
|
October 31, 1996
Calystegine B4, a novel trehalase inhibitor from Scopolia japonica
N Asano, A Kato, H Kizu, et al.
Page
of 5